MedPage Today on MSN
Study Compares GLP-1 Drugs on Their Benefits, Harms
Quality-of-life effects still a major unknown, researchers say ...
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), ...
Objective Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy characterised by pathological left ...
A systematic review and meta-analysis of seven cohort studies involving more than 40,000 GLP-1 receptor agonist-exposed ...
A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...
Objective To synthesise meta-analytic outcomes from randomised controlled trials examining exercise effects on depression and anxiety across all population groups, including children and adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results